ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.

ClinicalTrials.gov ID: NCT02554890

Public ClinicalTrials.gov record NCT02554890. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Double Dummy, Parallel Group, Active-controlled 8-week Study to Evaluate the Effect of Sacubitril/Valsartan (LCZ696) Versus Enalapril on Changes in NT-proBNP and Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Enalapril in HFrEF Patients Who Have Been Stabilized Following Hospitalization for Acute Decompensated Heart Failure (ADHF).

Study identification

NCT ID
NCT02554890
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
887 participants

Conditions and interventions

Interventions

  • Enalapril Drug
  • enalapril matching placebo Drug
  • sacubitril/valsartan (LCZ696) Drug
  • sacubitril/valsartan (LCZ696) matching placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2016
Primary completion
Jun 28, 2018
Completion
Jul 23, 2018
Last update posted
Jan 4, 2021

2016 – 2018

United States locations

U.S. sites
123
U.S. states
40
U.S. cities
108
Facility City State ZIP Site status
Novartis Investigative Site Birmingham Alabama 35294
Novartis Investigative Site Fort Smith Arkansas 72901
Novartis Investigative Site Little Rock Arkansas 72205
Novartis Investigative Site Bakersfield California 93301
Novartis Investigative Site Fresno California 93701
Novartis Investigative Site Long Beach California 90806
Novartis Investigative Site Los Angeles California 90033
Novartis Investigative Site Los Angeles California 90073
Novartis Investigative Site Orange California 92868
Novartis Investigative Site Pasadena California 91105
Novartis Investigative Site Sacramento California 95817-1460
Novartis Investigative Site San Diego California 92123
Novartis Investigative Site San Marino California 91108
Novartis Investigative Site San Pablo California 94806
Novartis Investigative Site Stanford California 94305
Novartis Investigative Site Denver Colorado
Novartis Investigative Site Littleton Colorado 80120
Novartis Investigative Site Bridgeport Connecticut 06610
Novartis Investigative Site Hartford Connecticut 06102
Novartis Investigative Site Hartford Connecticut 06105
Novartis Investigative Site West Haven Connecticut 06516
Novartis Investigative Site Washington D.C. District of Columbia 20422
Novartis Investigative Site Atlantis Florida 33462
Novartis Investigative Site Daytona Beach Florida 32117
Novartis Investigative Site Fort Lauderdale Florida 33308
Novartis Investigative Site Gainesville Florida 32608
Novartis Investigative Site Gainesville Florida 32610
Novartis Investigative Site Hollywood Florida 33021
Novartis Investigative Site Jacksonville Florida 32209-6511
Novartis Investigative Site Jacksonville Florida 32216
Novartis Investigative Site Lakeland Florida 33805
Novartis Investigative Site Sarasota Florida 34239
Novartis Investigative Site Tampa Florida 33612
Novartis Investigative Site Tampa Florida 34667
Novartis Investigative Site Vero Beach Florida 32960
Novartis Investigative Site Winter Haven Florida 33881
Novartis Investigative Site Augusta Georgia 30901
Novartis Investigative Site Macon Georgia 31201
Novartis Investigative Site Marietta Georgia 30060
Novartis Investigative Site Boise Idaho 83702
Novartis Investigative Site Aurora Illinois 60504
Novartis Investigative Site Elk Grove Village Illinois 60007
Novartis Investigative Site Oakbrook Terrace Illinois 60181
Novartis Investigative Site Park Ridge Illinois 60068
Novartis Investigative Site Peoria Illinois 61606
Novartis Investigative Site Peoria Illinois 61614
Novartis Investigative Site Winfield Illinois 60190
Novartis Investigative Site Elkhart Indiana 46514
Novartis Investigative Site Indianapolis Indiana 46202
Novartis Investigative Site Indianapolis Indiana 46237
Novartis Investigative Site Muncie Indiana 47303-3400
Novartis Investigative Site Richmond Indiana 47374
Novartis Investigative Site Des Moines Iowa 50314
Novartis Investigative Site Kansas City Kansas 66103
Novartis Investigative Site Louisville Kentucky 40205
Novartis Investigative Site Louisville Kentucky 40245
Novartis Investigative Site Alexandria Louisiana 71301
Novartis Investigative Site Baton Rouge Louisiana 70808
Novartis Investigative Site Slidell Louisiana 70458
Novartis Investigative Site Bangor Maine 04401
Novartis Investigative Site Annapolis Maryland 21401
Novartis Investigative Site Baltimore Maryland 21215
Novartis Investigative Site Boston Massachusetts 02215
Novartis Investigative Site Boston Massachusetts
Novartis Investigative Site Ann Arbor Michigan 48106
Novartis Investigative Site Bay City Michigan 48708
Novartis Investigative Site Detroit Michigan 48201
Novartis Investigative Site Maplewood Minnesota 55109
Novartis Investigative Site Minneapolis Minnesota 55417
Novartis Investigative Site Saint Paul Minnesota 55101
Novartis Investigative Site Saint Paul Minnesota 55102
Novartis Investigative Site Hattiesburg Mississippi 39401
Novartis Investigative Site Jackson Mississippi 39216
Novartis Investigative Site Kansas City Missouri 64108
Novartis Investigative Site Omaha Nebraska 68198
Novartis Investigative Site Reno Nevada 89502
Novartis Investigative Site Camden New Jersey 08103-3117
Novartis Investigative Site Elmer New Jersey 08318
Novartis Investigative Site Haddon Heights New Jersey 08035
Novartis Investigative Site Newark New Jersey 07102
Novartis Investigative Site Brooklyn New York 11215
Novartis Investigative Site Buffalo New York 14215
Novartis Investigative Site Johnson City New York 13790
Novartis Investigative Site Manhasset New York 11030
Novartis Investigative Site New York New York 10016
Novartis Investigative Site New York New York 10029
Novartis Investigative Site New York New York 10032
Novartis Investigative Site Poughkeepsie New York 12601
Novartis Investigative Site Rochester New York 14621
Novartis Investigative Site Staten Island New York 10310
Novartis Investigative Site The Bronx New York 10461
Novartis Investigative Site The Bronx New York 10467-2490
Novartis Investigative Site Chapel Hill North Carolina 27599
Novartis Investigative Site Greenville North Carolina 27834
Novartis Investigative Site Winston-Salem North Carolina 27157
Novartis Investigative Site Grand Forks North Dakota 58201
Novartis Investigative Site Cincinnati Ohio 45220
Novartis Investigative Site Toledo Ohio 43608
Novartis Investigative Site Oklahoma City Oklahoma 73122
Novartis Investigative Site Tulsa Oklahoma 74104
Novartis Investigative Site Abington Pennsylvania 19001
Novartis Investigative Site Camp Hill Pennsylvania 17011
Novartis Investigative Site Natrona Heights Pennsylvania 15065
Novartis Investigative Site Philadelphia Pennsylvania 19102 2293
Novartis Investigative Site Providence Rhode Island 02903
Novartis Investigative Site Charleston South Carolina 29403
Novartis Investigative Site Greenville South Carolina 29615
Novartis Investigative Site Rapid City South Dakota 57701
Novartis Investigative Site Nashville Tennessee 37203
Novartis Investigative Site Nashville Tennessee 37212
Novartis Investigative Site Dallas Texas 75204
Novartis Investigative Site Dallas Texas 75390
Novartis Investigative Site Houston Texas 77030
Novartis Investigative Site Plano Texas 75093
Novartis Investigative Site San Antonio Texas 78229
Novartis Investigative Site White River Junction Vermont 05009
Novartis Investigative Site Charlottesville Virginia 22908
Novartis Investigative Site Lynchburg Virginia 24501
Novartis Investigative Site Richmond Virginia 23298
Novartis Investigative Site Virginia Beach Virginia 23454
Novartis Investigative Site Clarksburg West Virginia 26301
Novartis Investigative Site Madison Wisconsin 53792-1615
Novartis Investigative Site Wausau Wisconsin 54401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02554890, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2021 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02554890 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →